PrevenTest > For Providers

PrevenTest > For Providers

WHAT is PreventTest?

For years, cancer screening and treatment has been limited to blood tests and conventional cookie-cutter therapy, but today things are different. Traditional assessments don't tell the entire story about a patient. Hereditary cancer screening helps clinicians determine the level of risk for some of the most common solid tumor cancers and helps identify risk and possible treatment options. 

PrevenTest is a non-invasive test developed by GeneID - Advanced Molecular Diagnostic Laboratories, to help clinicians and their patients directly assess their risk and their course of action.

 

Be the Link Between Genetic Risk and Cancer Prevention

Is PrevenTest Right for your Practice?

There is value in testing patients with and without cancer. 

This panel may be for patients that present with a history reflective of features typical of families with hereditary cancer syndromes such as:

  • A known familial mutation or limited knowledge of family history

  • A family / personal history of multiple relatives that have the same or linked cancer. 

  • A family / personal  history of cancers that were diagnosed at an abnormally  young age (<40 years of age)

  • A family or personal history of rare cancers (such as ovarian ,  pancreatic, or male breast

  • A family or personal history of cancers that developed in both organs of a paired organ set (such as both breasts or kidneys)

  • A personal history of cancer that occurred independently on the same patient. 

Why Preventest?